CID 11214940

Erastin

Structural Information

Molecular Formula
C30H31ClN4O4
SMILES
CCOC1=CC=CC=C1N2C(=O)C3=CC=CC=C3N=C2C(C)N4CCN(CC4)C(=O)COC5=CC=C(C=C5)Cl
InChI
InChI=1S/C30H31ClN4O4/c1-3-38-27-11-7-6-10-26(27)35-29(32-25-9-5-4-8-24(25)30(35)37)21(2)33-16-18-34(19-17-33)28(36)20-39-23-14-12-22(31)13-15-23/h4-15,21H,3,16-20H2,1-2H3
InChIKey
BKQFRNYHFIQEKN-UHFFFAOYSA-N
Compound name
2-[1-[4-[2-(4-chlorophenoxy)acetyl]piperazin-1-yl]ethyl]-3-(2-ethoxyphenyl)quinazolin-4-one
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

335
References

1293
Patents

546.20337 Da
Monoisotopic Mass

4.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 547.21065 232.6
[M+Na]+ 569.19259 237.4
[M-H]- 545.19609 239.0
[M+NH4]+ 564.23719 232.1
[M+K]+ 585.16653 229.8
[M+H-H2O]+ 529.20063 216.8
[M+HCOO]- 591.20157 237.5
[M+CH3COO]- 605.21722 236.6
[M+Na-2H]- 567.17804 230.4
[M]+ 546.20282 234.8
[M]- 546.20392 234.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe